The Food and Drug Administration's potential breakthrough drug for diabetes — which has the capacity to delay the onset of Type 1 diabetes — could be ready for high-risk patients before January.
Foes of the abortion pill are taking their fight to court, accusing the Food and Drug Administration of placing “politics over science” when it sanctioned the two-drug pregnancy-termination regimen in 2000.
Australian health officials said they will not make any changes to their existing recommendations for COVID-19 boosters — meaning they won’t recommend a third booster (fifth dose) for any age group, despite rising case and hospitalization numbers.